3 May 2014
Determinants of Health
policy, public health
The Union of Concerned Scientists is hosting a forum on Science, Democracy, and a Healthy Food Policy on Tuesday, 6 May 2014, at the University of Minnesota in Minneapolis–and will be available via live webcast.
The forum will provide an opportunity for policy makers, health advocates, and the public to learn how to improve food policy through science from effective local efforts across the United States.
Click here to learn more about the forum and to register.
24 Jul 2012
Diabetes Public Health: From Data to Policy is now available open access as a Google eBook. This book provides effective approaches to prevent and manage diabetes through the practice of public health. It focuses on diabetes control in the United States and North America, and it is recommended for public health practitioners and researchers and anyone involved in health policy, administration and management.
1. Narayan KMV, Williams D, Gregg EW, Cowie CC. Diabetes Public Health: From Data to Policy. New York: Oxford University Press, 2011.
17 Nov 2011
public health, smoking
The tobacco industry uses pseudo economic arguments to divert attention away from the health consequences of smoking to block new health regulations and ultimately protect its revenues, according to Tobacconomics, a report produced by Action on Smoking and Health.
The report debunks claims that support the three major pro-tobacco arguments developed by the industry and its lobbyists, which are recycled again and again for each new policy intervention: standing up for small businesses and defending workers’ jobs; raising the alarm about counterfeit and smuggled tobacco; and denying the effectiveness of tobacco control policies.
1. Action on Smoking and Health. Tobacconomics: How Big Tobacco Uses Dodgy Data to ‘Throw Sand in the Gears’ of Global Health Policy. London, UK: ASH, 2011.
17 Jun 2011
public health, smoking
The May 2011 supplement issue of Tobacco Control is focused on menthol cigarettes. All eight research papers are available open access.
Below are short summaries and links to each research paper.
1. Lee YO, Glantz SA. Menthol: putting the pieces together. Tobacco Control 2011; 20: ii1-ii7.
Information from tobacco industry documents consistently demonstrates that menthol facilitates and increases smoking and reduces quit smoking rates.
2. Anderson SJ, McCandless PM, Klausner K, et al. Tobacco documents research methodology. Tobacco Control 2011; 20: ii8-ii11.
This paper demonstrates the methodology used in researching tobacco documents.
3. Klausner K. Menthol cigarettes and smoking initiation: a tobacco industry perspective. Tobacco Control 2011; 20: ii12-ii19.
Menthol is a prominent design feature used by cigarette manufacturers to attract and retain new, younger smokers who perceive menthol cigarettes as less harsh and easier to smoke.
4. Anderson SJ. Marketing of menthol cigarettes and consumer perceptions: a review of tobacco industry documents. Tobacco Control 2011; 20: ii20-ii28.
Tobacco marketing emphasizing menthol attracts consumers who may not otherwise progress to regular smoking, including young, inexperienced users and those who find ‘regular’ cigarettes undesirable. Such marketing may also appeal to health-concerned smokers who might otherwise quit.
5. Yerger VB. Menthol’s potential effects on nicotine dependence: a tobacco industry perspective. Tobacco Control 2011; 20: ii29-ii36.
The tobacco industry knows that menthol overrides the harsh taste of tobacco and interacts with nicotine to produce tobacco products that are easier to smoke, thereby making it easier to expose smokers, especially those who are new, to the addictive power of nicotine.
6. Yerger VB, McCandless PM. Menthol sensory qualities and smoking topography: a review of tobacco industry documents. Tobacco Control 2011; 20: ii37-ii43.
If menthol in cigarettes was banned, new/experimental smokers might choose not to smoke rather than experience the harshness of tobacco smoke and the irritating qualities of nicotine. Similarly, established menthol smokers might choose to quit if faced with an unpleasant smoking alternative.
7. Salgado MV, Glantz SA. Direct disease-inducing effects of menthol through the eyes of tobacco companies. Tobacco Control 2011; 20: ii44-ii48.
The tobacco industry conducted little research on the potential disease-inducing effects of menthol and did not pursue studies that suggested adverse effects.
8. Anderson SJ. Menthol cigarettes and smoking cessation behaviour: a review of tobacco industry documents. Tobacco Control 2011; 20: ii49-ii56.
Menthol’s cooling and anesthetic effects that mask the short-term negative effects of smoking such as throat pain, burning and cough and the perception that menthol cigarettes are more socially acceptable provide a false assurance that would otherwise motivate smokers to quit.
16 Jun 2011
public health, smoking
Following the 1998 “Master Settlement Agreement” between the tobacco industry and 46 U.S. states, U.S. tobacco companies made their internal documents available on the internet. Research into these documents indicates that, in the past, tobacco companies enhanced the effects of smoking on appetite and weight by adding appetite-suppressant agents into cigarettes.
During the 1960s, tobacco giant Phillip Morris put a substance containing tartaric acid into its cigarettes in order to reduce smokers’ appetite. This substance was also added to British American Tobacco cigarettes, although researchers did not find at which date, and if it is still the case. The substance 2-acetylpyridine is also claimed as an appetite-reducing molecule and is one of the tobacco additives disclosed on many past lists of cigarette ingredients.
These are important findings in the fight against tobacco addiction because most smokers want to stop smoking, but the fear of weight gain sometimes outweighs the perception of potential health benefits associated with quitting smoking, particularly in women.
According to the study first published in April 2011 in the European Journal of Public Health, the findings may help smokers and the health care community to understand at least partially why cigarette smoking is producing the effect of reducing appetite, and could explain in part why smokers weigh in general less than non-smokers.
“Although little is known in the medical literature about the anti-appetite effect of the above cited substances, we can make the hypothesis that the weight gain following smoking cessation could be a ‘rebound effect’ of discontinuation of the daily consumption of an anti-appetite substance through cigarette smoking, as it is known for the use of other anti-appetite substances,” the study said.
1. Gonseth S, Jacot-Sadowski I, Diethelm PA, et al. The tobacco industry’s past role in weight control related to smoking. European Journal of Public Health, published online 7 April 2011. (open access)
26 Mar 2011
Cardiovascular Disease, Diabetes
heart disease, hypertension, public health, Switzerland
High blood pressure, high cholesterol and diabetes rates in Switzerland have increased in the last decade, according to data from three national health surveys conducted in 1997-2007.
The prevalence of self-reported hypertension, hypercholesterolemia and diabetes was 22.1 percent, 11.9 percent and 3.3 percent in 1997, respectively; and increased to 24.1 percent, 17.4 percent and 4.8 percent in 2007.
Self-reported treatment rates among people with these three cardiovascular risk factors also increased from 52.1 percent, 18.5 percent and 50 percent in 1997 to 60.4 percent, 38.8 percent and 53.3 percent in 2007 for hypertension, hypercholesterolemia and diabetes, respectively.
Self-reported control levels increased from 56.4 percent, 52.9 percent and 50 percent in 1997 to 80.6 percent, 75.1 percent and 53.3 percent in 2007. Finally, screening during the last 12 months increased from 84.5 percent, 86.5 percent and 87.4 percent in 1997 to 94 percent, 94.6 percent and 94.1 percent in 2007.
1. Estoppey D, Paccaud F, Vollenweider P, Marques-Vidal P. Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007. BMC Public Health 2011; 11: 114. (open access)
18 Mar 2011
global health, public health, smoking
Tobacco consumption has fallen over the past 20 years in the United States, Australia, Canada and most European countries; and so tobacco companies are turning their marketing efforts to low- and middle-income countries in Africa, Asia and Latin America to compensate for the loss of markets in high-income countries.
The tobacco industry has employed various strategies and tactics including cigarettes smuggling, recruiting of new and young smokers, denying the health consequences of smoking, manipulating governments to delay tobacco control legislations and the sponsoring of health professionals and academic institutions to act in their favor.
In addition to the negative health consequences, this focus has also fostered an economic dependence on tobacco in countries like Malawi and Brazil, who depend on tobacco exports.
Currently, there are over 1.2 billion tobacco users in the world. Around two-thirds of all smokers live in developing countries. Out of the total burden of tobacco-related diseases globally, 70 percent will occur in developing countries by 2030.
1. Doku D. The tobacco industry tactics—a challenge for tobacco control in low and middle income countries. African Health Sciences 2010; 10(2): 201-203. (open access)